Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.94 |
| ▸ | IDO1 | P14902 | 1/20 | 0.57 |
| ▸ | AGXT | P21549 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 2/20 | 0.48 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5311581 | 0.97 | TSHR (1.00) | TSHRIDO1AGXTCA1CA2 | |
| SCHEMBL27380 | 0.97 | TSHR (1.00) | TSHRIDO1AGXTCA1CA2 | |
| Barium SCHEMBL3798966 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| SCHEMBL10317949 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| SCHEMBL9491202 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| Water SCHEMBL10609439 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| Ammonia Solution, Strong SCHEMBL8645051 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| Water SCHEMBL15535487 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| Hydrochloric Acid SCHEMBL11878622 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 | |
| Lithium SCHEMBL586148 | 0.94 | TSHR (0.94) | TSHRIDO1AGXTCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 445 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630786-B2 | Solid composition comprising benzyloxide, sulfonate carrier, and non-hygroscopic acid, and its use in cleaning compositions | ECOLAB USA INC. (US) | 2026-05-19 | — | — | US | claimed |
| EP-4689040-A1 | SOLID BENZYLOXIDE COMPOSITIONS, METHODS OF MAKING, AND USE IN CLEANING | Ecolab USA Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024205939-A1 | SOLID BENZYLOXIDE COMPOSITIONS, METHODS OF MAKING, AND USE IN CLEANING | ECOLAB USA INC. (US) | 2024-10-03 | — | — | WO | claimed |
| US-20240318100-A1 | SOLID BENZYLOXIDE COMPOSITIONS, METHODS OF MAKING, AND USE IN CLEANING | ECOLAB USA INC. | 2024-09-26 | — | — | US | claimed |
| US-10968190-B2 | Processes for preparing oxathiazin-like compounds | GEISTLICH PHARMA AG (CH) | 2021-04-06 | — | — | US | claimed |
| US-10662190-B2 | Process for preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylate and oxalates thereof | XINFA PHARMACEUTICAL CO., LTD (CN) | 2020-05-26 | — | — | US | claimed |
| EP-3546451-A1 | IMPROVED METHOD FOR PREPARATION OF 5R | Xinfa Pharmaceutical Co., Ltd (CN) | 2019-10-02 | — | — | EP | claimed |
| US-20190256514-A1 | Process for Preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylate and Oxalates Thereof | XINFA PHARMACEUTICAL CO., LTD (CN) | 2019-08-22 | — | — | US | claimed |
| EP-3233813-A1 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | Geistlich Pharma AG (CH) | 2017-10-25 | — | — | EP | claimed |
| EP-3004047-B1 | COMPOUNDS OF '3-(5-SUBSTITUTED OXY-2,4-DINITRO-PHENYL)-2-OXO-PROPIONIC ACID ESTER', PROCESS AND APPLICATIONS THEREOF | ANTHEM BIOSCIENCES PVT LTD (IN) | 2017-02-22 | — | — | EP | claimed |
| US-20060173063-A1 | Exo-(t-butyl 2R(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate them | PFIZER INC. | 2006-08-03 | — | — | US | claimed |
| EP-1599483-A1 | EXO-(T-BUTYL 2R(+))-2-AMINO-7-AZABICYCLO 2.2.1 HEPTANE- 7-CARBOXYLATE, INTERMEDIATES, AND PROCESS TO PREPARE AND ISOLATE THEM | Pharmacia & Upjohn Company LLC (US) | 2005-11-30 | — | — | EP | claimed |
| EP-1591162-A1 | PROCESS FOR PRODUCTION OF ETHERS | KURARAY CO., LTD. (JP) | 2005-11-02 | — | — | EP | claimed |
| WO-2004074292-A1 | EXO-(T-BUTYL 2R(+))-2-AMINO-7-AZABICYCLO[2.2.1]HEPTANE-7-CARBOXYLATE, INTERMEDIATES, AND PROCESS TO PREPARE AND ISOLATE THEM | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-09-02 | — | — | WO | claimed |
| EP-0589034-A4 | METHOD FOR MAKING 3-G(A)-HYDROXY,3-G(B)-SUBSTITUTED-PREGNANES | COCENSYS INC (US) | 1996-05-22 | — | — | EP | claimed |
| US-5319115-A | Method for making 3α-hydroxy, 3β-substituted-pregnanes | COCENSYS INC. (US) | 1994-06-07 | — | — | US | claimed |
| EP-0589034-A1 | METHOD FOR MAKING 3$g(a)-HYDROXY,3$g(b)-SUBSTITUTED-PREGNANES | COCENSYS, INC. (US) | 1994-03-30 | — | — | EP | claimed |
| WO-1993018053-A1 | METHOD FOR MAKING 3α-HYDROXY,3β-SUBSTITUTED-PREGNANES | COCENSYS, INC. (US) | 1993-09-16 | — | — | WO | claimed |
| EP-0227450-A2 | Substituted 5,6-Dialkoxyquinazoline Derivatives | ORTHO PHARMACEUTICAL CORPORATION (US) | 1987-07-01 | — | — | EP | claimed |
| US-4051320-A | PROCESS FOR PREPARING ALKOXYLATED DERIVATIVES OF CEPHALOSPORIN COMPOUNDS | SANKYO COMPANY LIMITED (JA) | 1977-09-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173063-A1 | Exo-(t-butyl 2R(+))-2-amino-7-azabicyclo[2.2.1]heptane-7-carboxylate, intermediates, and process to prepare and isolate them | EXOC1, EXOC3, EXOC4 | TSHR 878/4885IDO1 797/4885AGXT 3069/4885 |
| US-20190256514-A1 | Process for Preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylate and Oxalates Thereof | OTC, CA1, GLUL | TSHR 3935/4885IDO1 2261/4885AGXT 40/4885 |
| US-10662190-B2 | Process for preparing 5R-[(benzyloxy) amino] piperidine-2S-carboxylate and oxalates thereof | OTC, CA1, GLUL | TSHR 3935/4885IDO1 2261/4885AGXT 40/4885 |
| US-10968190-B2 | Processes for preparing oxathiazin-like compounds | DCXR, SORD, ADH1C | TSHR 1284/4885IDO1 3343/4885AGXT 1048/4885 |
| US-12630786-B2 | Solid composition comprising benzyloxide, sulfonate carrier, and non-hygroscopic acid, and its use in cleaning compositions | HAO2, SMCHD1, ABCB11 | TSHR 3239/4885IDO1 3105/4885AGXT 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.